We are live on
!
Find out more
GCP
GSA Capital Partners Portfolio holdings
AUM
$1.59B
1-Year Est. Return
39.81%
This Fund
S&P 500
This Quarter
Est. Return
-2.76%
1 Year Est. Return
+39.81%
3 Year Est. Return
+94.75%
5 Year Est. Return
+73.44%
10 Year Est. Return
+404.29%
AUM
$754M
AUM Growth
+$87.8M
(+13%)
Cap. Flow
+$160M
Cap. Flow
% of AUM
21.21%
Top 10 Holdings %
Top 10 Hldgs %
3.31%
Holding
2,028
New
691
Increased
437
Reduced
328
Closed
568
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Dave & Buster's
PLAY
|
+$2.84M |
| 2 |
Live Nation Entertainment
LYV
|
+$2.81M |
| 3 |
Wolverine World Wide
WWW
|
+$2.72M |
| 4 |
Tesla
TSLA
|
+$2.63M |
| 5 |
CALY
Callaway Golf Company
CALY
|
+$2.58M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Genpact
G
|
+$3.61M |
| 2 |
Relay Therapeutics
RLAY
|
+$2.99M |
| 3 |
Extreme Networks
EXTR
|
+$2.33M |
| 4 |
Casey's General Stores
CASY
|
+$2.21M |
| 5 |
GTHX
G1 Therapeutics, Inc. Common Stock
GTHX
|
+$2.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 16.63% |
| 2 | Consumer Discretionary | 15.71% |
| 3 | Technology | 14.34% |
| 4 | Industrials | 12% |
| 5 | Financials | 11.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
RUBY
1426
DELISTED
Rubius Therapeutics, Inc
RUBY
| $48K | 0.01% |
111,323
-82,661
| -43% | -$62K |
|
1427
MarketWise
MKTW
$56.6M
| $46K | 0.01% |
1,012
-1,405
| -58% | -$82.8K |
|
|
CIAN
1428
DELISTED
Cian PLC American Depositary Shares, each representing one Ordinary Share
CIAN
| $46K | 0.01% |
13,492
| – | – |
|
1429
Gevo
GEVO
$382M
| $44K | 0.01% |
+19,180
| New | +$53.5K |
|
1430
Paysafe
PSFE
$375M
| $44K | 0.01% |
2,649
-648
| -20% | -$14.5K |
|
|
UXIN
1431
Uxin Ltd
UXIN
$282M
| $44K | 0.01% |
+740
| New | +$50.1K |
|
1432
Vroom Inc
VRM
$48.2M
| $41K | 0.01% |
+442
| New | +$59K |
|
1433
Opendoor
OPEN
$3.38B
| $40K | 0.01% |
13,265
-9,325
| -41% | -$42.8K |
|
|
NEUE
1434
DELISTED
NeueHealth
NEUE
| $40K | 0.01% |
+481
| New | +$63.8K |
|
1435
Organogenesis Holdings
ORGO
$239M
| $39K | 0.01% |
11,989
-22,391
| -65% | -$101K |
|
1436
Black Diamond Therapeutics
BDTX
$112M
| $38K | 0.01% |
+22,486
| New | +$69.3K |
|
|
TEF
1437
DELISTED
Telefonica
TEF
| $38K | 0.01% |
+11,610
| New | +$49.2K |
|
1438
Inseego
INSG
$90.5M
| $34K | ﹤0.01% |
+1,644
| New | +$39.7K |
|
|
RTB
1439
RTB Digital
RTB
$232M
| $32K | ﹤0.01% |
+95
| New | +$34.2K |
|
|
ONCT
1440
DELISTED
Oncternal Therapeutics, Inc. Common Stock
ONCT
| $31K | ﹤0.01% |
1,751
-6,264
| -78% | -$134K |
|
1441
Ceragon Networks
CRNT
$201M
| $30K | ﹤0.01% |
16,292
-4,646
| -22% | -$11.1K |
|
|
LTCH
1442
DELISTED
Latch, Inc. Common Stock
LTCH
| $30K | ﹤0.01% |
+31,609
| New | +$36.2K |
|
|
CGC
1443
Canopy Growth
CGC
$410M
| $29K | ﹤0.01% |
+1,077
| New | +$33.2K |
|
|
FSP
1444
Franklin Street Properties
FSP
$46.8M
| $29K | ﹤0.01% |
+10,856
| New | +$35.8K |
|
1445
Ouster
OUST
$2.92B
| $25K | ﹤0.01% |
+2,606
| New | +$40.1K |
|
1446
Geron
GERN
$949M
| $24K | ﹤0.01% |
+10,352
| New | +$23.2K |
|
|
FABC
1447
Fabric.AI Inc
FABC
$18.4M
| $22K | ﹤0.01% |
297
-550
| -65% | -$62.9K |
|
1448
Senseonics Holdings Inc
SENS
$366M
| $22K | ﹤0.01% |
841
-16,305
| -95% | -$499K |
|
1449
Taboola.com
TBLA
$1.11B
| $21K | ﹤0.01% |
11,565
-118,393
| -91% | -$305K |
|
1450
Microvast
MVST
$302M
| $20K | ﹤0.01% |
+10,815
| New | +$25.9K |
|
Similar funds
NCL
DG
VNT
SS
GWANC
LCM
LCM
FDCP
GSA Capital Partners's Q3 2022 Portfolio in Review
As of Q3 2022, GSA Capital Partners held 2,028 positions worth $754M, up 13% from $666M the previous quarter. Its ten largest holdings account for 3.3% of the portfolio.
GSA Capital Partners deployed $160M of net new capital in Q3 2022, opening 691 new positions and adding to 437 existing holdings. Its largest new stake was Dave & Buster's: 75,954 shares worth $2.36M.
By sector, the portfolio is most concentrated in Healthcare at 17% of assets, down from 18% a quarter earlier, followed by Consumer Discretionary and Technology.
On the sell side, the largest reduction was Genpact, an estimated $3.61M trimmed.
- GSA Capital Partners's largest Q3 2022 buy was Dave & Buster's: 75,954 shares worth $2.36M.
- GSA Capital Partners added most to Grocery Outlet in Q3 2022, an estimated $2.54M increase.
- GSA Capital Partners's biggest Q3 2022 reduction was Genpact, cutting an estimated $3.61M.
- GSA Capital Partners fully exited Relay Therapeutics in Q3 2022, selling an estimated $2.99M.
- GSA Capital Partners's ten largest holdings make up 3.3% of its $754M portfolio in Q3 2022.
- GSA Capital Partners opened 691 new positions and closed 568 in Q3 2022.
- GSA Capital Partners's portfolio value rose 13% quarter-over-quarter to $754M.
Based on GSA Capital Partners's 13F filing for Q3 2022, filed 14 Nov 2022.